Alterity Therapeutics
€0.01
25
-€0-28.57% Wednesday 06:12
Statistics
Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
54.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
25FebExpected
Expected EPS
-0.0005389060173610135
Actual EPS
-0.000843505070652021
Financials
-Profit Margin
Unprofitable0Revenue
-13.84MNet Income
Analyst Ratings
$0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PBN.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Palatin Technologies
PTN
Mkt Cap2.45M
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
AnaptysBio
ANAB
Mkt Cap1.02B
Anavex Life Sciences
AVXL
Mkt Cap684.57M
Axsome Therapeutics
AXSM
Mkt Cap6.74B
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Prothena
PRTA
Mkt Cap578.67M
Voyager Therapeutics
VYGR
Mkt Cap259.04M
About
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
Show more...
CEO
Mr. Geoffrey Paul Kempler B.Sc.
Employees
9
Country
AU
ISIN
AU0000043945
WKN
000A2PHDZ
Listings
0 Comments
Share your thoughts
FAQ
What is Alterity Therapeutics stock price today?▼
The current price of PBN.F is €0.01 EUR — it has decreased by -28.57% in the past 24 hours. Watch Alterity Therapeutics stock price performance more closely on the chart.
What is Alterity Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alterity Therapeutics stocks are traded under the ticker PBN.F.
Is Alterity Therapeutics stock price growing?▼
PBN.F stock has risen by +0% compared to the previous week, the month change is a +150% rise, over the last year Alterity Therapeutics has showed a +42.86% increase.
What is Alterity Therapeutics market cap?▼
Today Alterity Therapeutics has the market capitalization of 54.38M
When is the next Alterity Therapeutics earnings date?▼
Alterity Therapeutics is going to release the next earnings report on August 28, 2026.
What were Alterity Therapeutics earnings last quarter?▼
PBN.F earnings for the last quarter are -0 EUR per share, whereas the estimation was -0 EUR resulting in a -56.52% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Alterity Therapeutics revenue for the last year?▼
Alterity Therapeutics revenue for the last year amounts to 0 EUR.
What is Alterity Therapeutics net income for the last year?▼
PBN.F net income for the last year is -13.84M EUR.
How many employees does Alterity Therapeutics have?▼
As of April 02, 2026, the company has 9 employees.
In which sector is Alterity Therapeutics located?▼
Alterity Therapeutics operates in the Health Care sector.
When did Alterity Therapeutics complete a stock split?▼
The last stock split for Alterity Therapeutics was on January 09, 2023 with a ratio of 1:10.
Where is Alterity Therapeutics headquartered?▼
Alterity Therapeutics is headquartered in Melbourne, AU.